BioWorld-International-2003-12-17
Acambis Files 'First-Ever' BLA: Arilvax Vaccine In Yellow Fever
Acambis Files 'First-Ever' BLA: Arilvax Vaccine In Yellow Fever
Acambis plc filed a biologics license application seeking approval of Arilvax as a vaccine to prevent yellow fever. (BioWorld International)

